Metabolic Outcomes in a Randomized Trial of Nucleoside, Nonnucleoside and Protease Inhibitor-Sparing Regimens for Initial HIV Treatment

BACKGROUND: The metabolic effects of initial therapy for HIV-1 infection are important determinants of regimen selection. METHODS: Open-label study in 753 subjects randomized equally to: efavirenz or lopinavir/ritonavir(r) plus two NRTI versus the NRTI-sparing regimen of lopinavir/r plus efavirenz....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Haubrich, Richard H., Riddler, Sharon A., DiRienzo, A. Gregory, Komarow, Lauren, Powderly, William G., Klingman, Karin, Garren, Kevin W., Butcher, David L., Rooney, James F., Haas, David W., Mellors, John W., Havlir, Diane V.
Formato: Artigo
Idioma:English
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2739977/
https://ncbi.nlm.nih.gov/pubmed/19417580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32832b4377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2739977/
https://ncbi.nlm.nih.gov/pubmed/19417580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32832b4377

Registos relacionados